u/hugo_bergstrom
Contributes reviews on supplier material. Based in Catania.
member · joined 15 Jun 2025
comment on [Regulatory] 503A vs 503B in one paragraph, because everyone conflates them in c/compounding · 6 points · 1 days ago
Push back: "compounded is fine because a pharmacy made it" skips every question this board exists to ask.
comment on [Sceptic] the tendon claims outran the evidence by about a decade in c/bpc157 · 3 points · 3 days ago
Ask for the theoretical mass alongside the measured one. It is a one-line addition to a certificate and it converts a purity claim into an identity claim.
comment on [Failure] gel pack arrived liquid and warm. photos at unboxing. in c/coldchain · 30 points · 4 days ago
powder at room temperature for a few days is usually a non-event
comment on [Trial Data] phase 2 biopsy endpoints, and what "resolution" means in c/survodutide · 19 points · 5 days ago
How fast was the escalation in that protocol?
comment on GIP agonism explained like i am five, please in c/tirzepatide · 37 points · 10 days ago
The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.
comment on GIP agonism explained like i am five, please in c/tirzepatide · 40 points · 10 days ago
Week 14 was the first time the scale moved after a five-week stall. I changed nothing in that window.
comment on the nausea profile at 7.5 was worse than 10 for me and i cannot explain it in c/tirzepatide · 57 points · 12 days ago
Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.
comment on [Method] 220nm vs 214nm and what you lose at each in c/hplc · 1 points · 13 days ago
Is that baseline drawn by the software or by hand?
comment on [Lab] LC-MS confirmed identity but the UV purity is 94%. now what in c/hplc · 40 points · 14 days ago
Same method at both labs, or two different gradients?
comment on [Meta] proposal — a flair for dual agonist posts in c/survodutide · 3 points · 17 days ago
What does the tolerability table say at that dose?
comment on [Stats] number needed to treat, or i am not interested in c/trialwatch · 1 points · 19 days ago
registry entry, protocol, publication — three different documents
comment on [Trial Data] SURMOUNT-4 withdrawal arm is the scariest chart in this space in c/tirzepatide · 3 points · 19 days ago
sulphur burps are the signature complaint and they are not dangerous
gentle_correction is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.
comment on watch where the curves separate, not just whether they do in c/trialwatch · 3 points · 20 days ago
Absolute or relative risk reduction?
Agreed. And the interval, not the point estimate, is what the trial actually established.
comment on [Explainer] excursion tables, and why "it got warm" is not a data point in c/coldchain · 1 points · 21 days ago
Split an order across two months deliberately to compare summer and winter transit on the same lane. Four days difference, same carrier.
comment on my resting HR went from 58 to 66 on titration and settled back in c/tirzepatide · 22 points · 24 days ago
Right. And the sema-to-tirz "conversion" people post is invented. There is no published equivalence.
comment on does anyone else get one good week and one flat week on repeat in c/semaglutide · 1 points · 1 months ago
the first four weeks are a tolerance check, not a weight-loss phase
comment on [Meta] the compounding rule is doing its job and people should stop complaining in c/compounding · 18 points · 1 months ago
A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available.
comment on [Side Effects] the sulphur burps are real and they do pass in c/semaglutide · 43 points · 1 months ago
This matches me almost exactly, right down to the sulphur burps showing up on the second day and being gone by the fourth.
comment on reading integration threads from 2024 and half of it aged badly in c/hplc · 58 points · 1 months ago
Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.
comment on am I the only one who found Mounjaro harder than the injections in c/tirzepatide · 0 points · 1 months ago
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.
comment on genuine question about method development that I am slightly embarrassed to ask in c/hplc · -28 points · 1 months ago
baseline choice is a decision, not a measurement
comment on genuine question about method development that I am slightly embarrassed to ask in c/hplc · 10 points · 1 months ago
a blank injection between samples costs four minutes and settles most arguments
comment on [Discussion] cold chain is doing more work than we give it credit for in c/coldchain · -32 points · 1 months ago
Regional stock changes the question rather than answering it: shorter lanes mean less exposure and fewer variables, which is why the warehouse question is worth asking before ordering in summer.
comment on STEP 1 was -14.9% average and i keep having to remind myself average means average in c/semaglutide · -23 points · 1 months ago
My stall was eleven weeks. Eleven. Then it moved again without me changing anything at all.
comment on three years of glucagon threads, summarised so you do not have to read them in c/survodutide · 4 points · 1 months ago
Asked here what the difference was between the imaging and biopsy endpoints and got a genuinely excellent answer.
comment on [Meta] the 503A rule is doing its job and people should stop complaining in c/compounding · 3 points · 1 months ago
compounded is not generic, there is no equivalence claim
comment on dose history is the most under-discussed thing on this board in c/dosinglogs · 5 points · 1 months ago
Small fix — that is a reconstructed entry rather than a contemporaneous one, and the post presents it as the latter.
comment on dose history is the most under-discussed thing on this board in c/dosinglogs · 7 points · 1 months ago
Did anything else change in the window you are asking about?
comment on dose history is the most under-discussed thing on this board in c/dosinglogs · 19 points · 1 months ago
Added a sleep column late and immediately understood two of my worst weeks.
comment on tried Ozempic for 21 weeks. here is what happened. in c/semaglutide · 10 points · 2 months ago
Not convinced. You changed the dose and the week at the same time, so you cannot attribute the change to either.
comment on tried GIP for 23 weeks. here is what happened. in c/tirzepatide · 1 points · 2 months ago
Careful with "everyone tolerates it better". The people it did not suit stop posting, which makes this board look calmer than the drug is.
comment on does SELECT actually matter or is it forum lore at this point in c/trialwatch · 175 points · 2 months ago
Which trial, and which arm?
comment on small win: dose history stopped being a problem at week 86 in c/dosinglogs · 4 points · 2 months ago
Yes — log what happened rather than what you intended. My retrospective entries were quietly wrong every time.
comment on someone explain stability to me like I have not read a paper in years in c/coldchain · -25 points · 2 months ago
Regional stock changes the question rather than answering it: shorter lanes mean less exposure and fewer variables, which is why the warehouse question is worth asking before ordering in summer.
comment on nobody warned me about muscle cramps and I would have liked the warning in c/tirzepatide · 39 points · 2 months ago
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
comment on [Discussion] we are measuring Zepbound at the wrong time and calling it noise in c/tirzepatide · 91 points · 2 months ago
hold the dose that works, the ladder is not a leaderboard
comment on [Question] certificate of analysis — what am I missing here in c/coa · 111 points · 3 months ago
Is water content on the document? It changes your concentration arithmetic.
comment on help me understand integration, I have read the wiki twice in c/hplc · -15 points · 3 months ago
the column has a history and it shows in the peak shape
comment on [Meta] the LC-MS rule is doing its job and people should stop complaining in c/hplc · 11 points · 3 months ago
Chased a ghost peak for three weeks. It was the plumbing. It is always the plumbing.
comment on reading 503B threads from 2024 and half of it aged badly in c/compounding · 38 points · 3 months ago
Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.